Professor Jeffrey Gerst’s laboratory at Israel’s Weizmann Institute of Science had an unaddressed need, so IDEA Bio-Medical designed a new HERMES 24/7 completely autonomous imaging platform. Hermes 24/7, which was inspired by customers, sets a new standard for simplicity and compactness in fully automated, image-based experimentation.
I wanted a high content imaging system that was reliable at high magnifications for screening the relative localization between mRNA and organelles in yeast.
My main goal while searching for a suitable supplier was minimizing the number of external suppliers I would have to interact with and address.
In this aspect, IDEA Bio-Medical offered me an integrative solution that included the image acquisition and analysis, together with interfacing of the microscope to existing systems I already had. Such a comprehensive solution from a single company significantly simplified the whole process. This was a huge advantage.”
Jeffrey Gerst, Professor, Molecular Genetics, Weizmann Institute of Science
Professor Gerst’s requirements were custom-tailored by IDEA Bio-Medical, taking advantage of the accomplished in-house software development teams and expert knowledge in concise motion system development and manufacturing.
IDEA Bio-Medical aimed to equip laboratories outside of the Gerst lab to use current facilities to expand their capabilities while minimizing the amount of useful lab space occupied when developing the new Hermes 24/7 automated system.
Prof. Jeffrey Gerst of the Weizmann Institute’s Molecular Genetics Department. Image Credit: IDEA Bio-Medical Ltd.
The Hermes 24/7 system at the Gerst lab, Weizmann Institute. The system is integrated to a Freedom Evo liquid handler by Tecan. Image Credit: IDEA Bio-Medical Ltd.
About IDEA Bio-Medical Ltd.
IDEA Bio-Medical is founded in 2007 through a partnership between YEDA (the Weizmann Institute’s commercialization arm) and IDEA Machine Development (an innovation hub).
We specialize in automated imaging systems and image analysis software, offering a broad range of biological applications based on the company’s unique algorithms library. The company is developing novel image-based screening platforms for the pharmaceutical industry and medical centers, dedicated to broadening the scope of personalized medicine.
Our WiScan Hermes system incorporates the most advanced technologies currently available in the machine vision field, integrated with engineering methodologies of high reliability and quality at the level of semi-conductors and digital printing industries, which are the specialty of our mother company, IDEA Machine Development Design and Production Ltd.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.